Rilpivirine

Records for this ingredient, by country (identity only).

ATC J05AG05 · 12 markets · 66 records

Rilpivirine 12 markets · 66 records Forms

Filters

MarketAU 12 US 9 GB 7 CA 6 EU 6 ES 5 HK 5 JP 5 TW 4 SG 2 MX 1 FR 1

Kind

Strength

AU 12 records · 6 shown of 6 Source TGA、PBS Schedule API v3 (Department of +1 · Data as of 2026-10-28、live · some records have no stated strength · includes records with unknown status (not proof of sale)

Only this ingredient

25 mgtabletEDURANT also in US·GB·CA
+3Other 3 markets
ES JP TW

Combination products containing this ingredient

25 mgtablet CombinationDolutegravir 50 mg + Rilpivirine 25 mgJuluca also in US·GB·CA
900 mg/3 mLinjection · extended-release CombinationCabotegravir 600 mg/3 mL + Rilpivirine 900 mg/3 mLCabenuva
900 mg per mL / per unit basis not statedinjection CombinationCabotegravir 600 mg + Rilpivirine 900 mgCABENUVA cabotegravir 600 mg/3 mL plus rilpivirine 900 mg/3 mL prolonged-release suspensions for injection vials unknown
600 mg per mL / per unit basis not statedinjection CombinationCabotegravir 400 mg + Rilpivirine 600 mgCABENUVA cabotegravir 600 mg/3 mL plus rilpivirine 900 mg/3 mL prolonged-release suspensions for injection vials unknown
25 mgtablet CombinationEmtricitabine 200 mg + Rilpivirine 25 mg + Tenofovir Alafenamide 25 mgODEFSEY also in US·GB·CA
+1Other 1 markets
ES

6 records · 0 manufacturers 6 registros · 0 fabricantes 6 个记录 · 0 个厂家 6 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名Cabenuva ×2EDURANT ×12Juluca ×4ODEFSEY ×12RILPEMVI ×2TRILPIVI ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

US 9 records · 5 shown of 5 Source openFDA NDC Directory · Data as of 2026-10-23

Only this ingredient

25 mgtabletEDURANT+2Manufacturer: Laurus Labs Limited、Manufacturer: Somerset Therapeutics, LLC also in AU·GB·CA
+3Other 3 markets
ES JP TW
2.5 mgtabletEDURANT PED also in GB

Combination products containing this ingredient

25 mgtablet CombinationDolutegravir 50 mg + Rilpivirine 25 mgJuluca also in AU·GB·CA
25 mgtablet CombinationEmtricitabine 200 mg + Rilpivirine 25 mg + Tenofovir Alafenamide 25 mgODEFSEY also in AU·GB·CA
+1Other 1 markets
ES
25 mgtablet CombinationEmtricitabine 200 mg + Rilpivirine 25 mg + Tenofovir Disoproxil 300 mgCOMPLERA+2Manufacturer: Laurus Labs Limited、Manufacturer: Mylan Pharmaceuticals Inc. also in CA

GB 7 records · 6 shown of 6 Source NHSBSA dm+d · Data as of 2026-10-19

Only this ingredient

25 mgtabletEDURANT also in AU·US·CA
+3Other 3 markets
ES JP TW
2.5 mgtabletEDURANT also in US
900 mg/3 mLinjection · extended-releaseRekambys 900mg/3ml prolonged-release suspension for injection vials also in FR

Combination products containing this ingredient

25 mgtablet CombinationDolutegravir 50 mg + Rilpivirine 25 mgJuluca also in AU·US·CA
25 mgtablet CombinationEmtricitabine 200 mg + Rilpivirine 25 mg + Tenofovir Alafenamide 25 mgODEFSEY also in AU·US·CA
+1Other 1 markets
ES
25 mgtablet CombinationEmtricitabine 200 mg + Rilpivirine 25 mg + Tenofovir Disoproxil 245 mgEviplera 200mg/25mg/245mg tablets+1Manufacturer: Gilead Sciences Ltd also in ES

CA 6 records · 5 shown of 5 Source Health Canada Drug Product Databas · Data as of 2026-10-23

Only this ingredient

25 mgtabletEDURANT also in AU·US·GB
+3Other 3 markets
ES JP TW

Combination products containing this ingredient

25 mgtablet CombinationDolutegravir 50 mg + Rilpivirine 25 mgJuluca also in AU·US·GB
300 mg per mL / per unit basis not statedliquid · extended-release CombinationCabotegravir 200 mg + Rilpivirine 300 mgCabenuva
25 mgtablet CombinationEmtricitabine 200 mg + Rilpivirine 25 mg + Tenofovir Alafenamide 25 mgODEFSEY also in AU·US·GB
+1Other 1 markets
ES
25 mgtablet CombinationEmtricitabine 200 mg + Rilpivirine 25 mg + Tenofovir Disoproxil 300 mgCOMPLERA also in US

EU 6 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

6 records · 0 manufacturers 6 registros · 0 fabricantes 6 个记录 · 0 个厂家 6 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名EDURANT ×6Emtricitabine/Rilpivirine/Tenofovir Alafenamide Viatris ×1Eviplera 200mg/25mg/245mg tablets ×3Juluca ×4ODEFSEY ×6REKAMBYS ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

ES 5 records · 4 shown of 4 Source CIMA (AEMPS) · Data as of live · some records have no stated strength

Only this ingredient

25 mgtabletEDURANT also in AU·US·GB
+3Other 3 markets
CA JP TW
900 mg per mL / per unit basis not statedinjection · extended-releaseREKAMBYS

Combination products containing this ingredient

25 mgtablet CombinationEmtricitabine 200 mg + Rilpivirine 25 mg + Tenofovir Alafenamide 25 mgODEFSEY also in AU·US·GB
+1Other 1 markets
CA
25 mgtablet CombinationEmtricitabine 200 mg + Rilpivirine 25 mg + Tenofovir Disoproxil 245 mgEviplera 200mg/25mg/245mg tablets also in GB

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名Juluca ×4

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

HK 5 records · 0 shown of 0 Source 衞生署藥物辦公室（香港）註冊藥劑製品名單 · Data as of 2026-10-23 · some records have no stated strength · includes records with unknown status (not proof of sale)

5 records · 0 manufacturers 5 registros · 0 fabricantes 5 个记录 · 0 个厂家 5 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名EDURANT ×6ODEFSEY ×12REKAMBYS PROLONGED-RELEASE SUSPENSION FOR INJECTION 600MG/2ML ×4

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

JP 5 records · 3 shown of 3 Source 厚生労働省薬価基準収載品目リスト · Data as of 2026-11-01 · some records have no stated strength

Only this ingredient

25 mgtabletエジュラント錠25mg also in AU·US·GB
+3Other 3 markets
CA ES TW
900 mg/3 mLinjectionリカムビス水懸筋注900mg
600 mg/2 mLinjectionリカムビス水懸筋注900mg

2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名オデフシィ配合錠 ×1ジャルカ配合錠 ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

TW 4 records · 2 shown of 2 Source 衛生福利部食品藥物管理署（TFDA）全部藥品許可證資料集 · Data as of 2026-10-22 · some records have no stated strength

Only this ingredient

25 mgtabletEDURANT+1恩臨®膜衣錠25毫克 also in AU·US·GB
+3Other 3 markets
CA ES JP
300 mg per mL / per unit basis not statedinjection · extended-releaseRekambys prolonged-release suspension for injection 300 mg/mL+1瑞卡必持續性藥效注射懸浮劑300毫克/毫升

2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名Juluca ×4ODEFSEY ×6安以斯膜衣錠 ×1滋若愷膜衣錠 ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

SG 2 records · 2 shown of 2 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

Only this ingredient

300 mg/mL per mL / per unit basis not statedinjection · extended-releaseRekambys prolonged-release suspension for injection 300 mg/mL

Combination products containing this ingredient

25 mgtablet CombinationEmtricitabine 200 mg + Rilpivirine 25 mg + Tenofovir Alafenamide Fumarate 25 mgODEFSEY

MX 1 records · 0 shown of 0 Source COFEPRIS · Data as of annual · some records have no stated strength

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名REKAMBYS ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

FR 1 records · 1 shown of 1 Source Base de données publique des médic · Data as of 2026-11-03

Only this ingredient

900 mg/3 mLinjection · extended-releaseREKAMBYS 900 mg, suspension injectable à libération prolongée also in GB

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

Side-by-side table

Strength / form / release	US	GB	CA	AU	SG	ES	MX	TW	HK	JP	EU	FR
25 mg tablet	Manufacturer: Laurus Labs Limited ×2 Manufacturer: Somerset Therapeutics, LLC EDURANT	EDURANT	EDURANT	EDURANT	not recorded	EDURANT	not recorded	EDURANT 恩臨®膜衣錠25毫克	not recorded	エジュラント錠25mg	not recorded	not recorded
2.5 mg tablet	EDURANT PED	EDURANT	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
900 mg/3 mL injection · extended-release	not recorded	Rekambys 900mg/3ml prolonged-release suspension for injection vials	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	REKAMBYS 900 mg, suspension injectable à libération prolongée
300 mg per mL / per unit basis not stated cannot compare injection · extended-release	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	Rekambys prolonged-release suspension for injection 300 mg/mL 瑞卡必持續性藥效注射懸浮劑300毫克/毫升	not recorded	not recorded	not recorded	not recorded
900 mg per mL / per unit basis not stated cannot compare injection · extended-release	not recorded	not recorded	not recorded	not recorded	not recorded	REKAMBYS	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
900 mg/3 mL injection	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	リカムビス水懸筋注900mg	not recorded	not recorded
600 mg/2 mL injection	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	リカムビス水懸筋注900mg	not recorded	not recorded
300 mg/mL per mL / per unit basis not stated cannot compare injection · extended-release	not recorded	not recorded	not recorded	not recorded	Rekambys prolonged-release suspension for injection 300 mg/mL	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
25 mg Combination Dolutegravir 50 mg + Rilpivirine 25 mg tablet	Juluca	Juluca	Juluca	Juluca	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
300 mg per mL / per unit basis not stated cannot compare Combination Cabotegravir 200 mg + Rilpivirine 300 mg liquid · extended-release	not recorded	not recorded	Cabenuva	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
900 mg/3 mL Combination Cabotegravir 600 mg/3 mL + Rilpivirine 900 mg/3 mL injection · extended-release	not recorded	not recorded	not recorded	Cabenuva	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
900 mg per mL / per unit basis not stated cannot compare Combination Cabotegravir 600 mg + Rilpivirine 900 mg injection	not recorded	not recorded	not recorded	CABENUVA cabotegravir 600 mg/3 mL plus rilpivirine 900 mg/3 mL prolonged-release suspensions for injection vials	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
600 mg per mL / per unit basis not stated cannot compare Combination Cabotegravir 400 mg + Rilpivirine 600 mg injection	not recorded	not recorded	not recorded	CABENUVA cabotegravir 600 mg/3 mL plus rilpivirine 900 mg/3 mL prolonged-release suspensions for injection vials	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
25 mg Combination Emtricitabine 200 mg + Rilpivirine 25 mg + Tenofovir Alafenamide 25 mg tablet	ODEFSEY	ODEFSEY	ODEFSEY	ODEFSEY	not recorded	ODEFSEY	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
25 mg Combination Emtricitabine 200 mg + Rilpivirine 25 mg + Tenofovir Disoproxil 300 mg tablet	Manufacturer: Laurus Labs Limited ×2 Manufacturer: Mylan Pharmaceuticals Inc. COMPLERA	not recorded	COMPLERA	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
25 mg Combination Emtricitabine 200 mg + Rilpivirine 25 mg + Tenofovir Disoproxil 245 mg tablet	not recorded	Manufacturer: Gilead Sciences Ltd Eviplera 200mg/25mg/245mg tablets	not recorded	not recorded	not recorded	Eviplera 200mg/25mg/245mg tablets	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
25 mg Combination Emtricitabine 200 mg + Rilpivirine 25 mg + Tenofovir Alafenamide Fumarate 25 mg tablet	not recorded	not recorded	not recorded	not recorded	ODEFSEY	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
not disclosed unknown	not recorded	not recorded	not recorded	EDURANT	not recorded	not recorded	not recorded	not recorded	EDURANT REKAMBYS PROLONGED-RELEASE SUSPENSION FOR INJECTION 600MG/2ML	not recorded	EDURANT REKAMBYS	not recorded
not disclosed liquid	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	REKAMBYS	not recorded	not recorded	not recorded	not recorded	not recorded
not disclosed Combination Dolutegravir + Rilpivirine tablet	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	Juluca 滋若愷膜衣錠	not recorded	ジャルカ配合錠	not recorded	not recorded
not disclosed Combination Dolutegravir + Rilpivirine unknown	not recorded	not recorded	not recorded	Juluca	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	Juluca	not recorded
not disclosed Combination Dolutegravir 50 mg + Rilpivirine tablet	not recorded	not recorded	not recorded	not recorded	not recorded	Juluca	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
not disclosed Combination Cabotegravir + Rilpivirine unknown	not recorded	not recorded	not recorded	Cabenuva	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
not disclosed Combination Emtricitabine + Rilpivirine + Rilpivirine + Tenofovir Alafenamide unknown	not recorded	not recorded	not recorded	RILPEMVI TRILPIVI	not recorded	not recorded	not recorded	not recorded	ODEFSEY	not recorded	Emtricitabine/Rilpivirine/Tenofovir Alafenamide Viatris ODEFSEY	not recorded
not disclosed Combination Emtricitabine + Rilpivirine + Tenofovir Alafenamide tablet	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	ODEFSEY 安以斯膜衣錠	not recorded	オデフシィ配合錠	not recorded	not recorded
not disclosed Combination Emtricitabine + Rilpivirine + Tenofovir Disoproxil unknown	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	Eviplera 200mg/25mg/245mg tablets	not recorded
not disclosed Combination Emtricitabine + Rilpivirine + Rilpivirine + Tenofovir + Tenofovir Alafenamide unknown	not recorded	not recorded	not recorded	ODEFSEY	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

11 more strength/form rows are recorded only in GB · CA · SG · ES · MX · JP · EU · FR and are not shown in this table. Hay 11 filas de concentración/forma registradas solo en GB · CA · SG · ES · MX · JP · EU · FR que no se muestran en esta tabla. 另有 11 个规格/剂型仅在 GB · CA · SG · ES · MX · JP · EU · FR 有记录（未在本表显示）。另有 11 個規格/劑型僅在 GB · CA · SG · ES · MX · JP · EU · FR 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

Rilpivirine

AU 12 records · 6 shown of 6 Source TGA、PBS Schedule API v3 (Department of +1 · Data as of 2026-10-28、live · some records have no stated strength · includes records with unknown status (not proof of sale)

Only this ingredient

Combination products containing this ingredient

US 9 records · 5 shown of 5 Source openFDA NDC Directory · Data as of 2026-10-23

Only this ingredient

Combination products containing this ingredient

GB 7 records · 6 shown of 6 Source NHSBSA dm+d · Data as of 2026-10-19

Only this ingredient

Combination products containing this ingredient

CA 6 records · 5 shown of 5 Source Health Canada Drug Product Databas · Data as of 2026-10-23

Only this ingredient

Combination products containing this ingredient

EU 6 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

ES 5 records · 4 shown of 4 Source CIMA (AEMPS) · Data as of live · some records have no stated strength

Only this ingredient

Combination products containing this ingredient

HK 5 records · 0 shown of 0 Source 衞生署藥物辦公室（香港）註冊藥劑製品名單 · Data as of 2026-10-23 · some records have no stated strength · includes records with unknown status (not proof of sale)

JP 5 records · 3 shown of 3 Source 厚生労働省 薬価基準収載品目リスト · Data as of 2026-11-01 · some records have no stated strength

Only this ingredient

TW 4 records · 2 shown of 2 Source 衛生福利部食品藥物管理署（TFDA）全部藥品許可證資料集 · Data as of 2026-10-22 · some records have no stated strength

Only this ingredient

SG 2 records · 2 shown of 2 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

Only this ingredient

Combination products containing this ingredient

MX 1 records · 0 shown of 0 Source COFEPRIS · Data as of annual · some records have no stated strength

FR 1 records · 1 shown of 1 Source Base de données publique des médic · Data as of 2026-11-03

Only this ingredient

JP 5 records · 3 shown of 3 Source 厚生労働省薬価基準収載品目リスト · Data as of 2026-11-01 · some records have no stated strength